Guide to buying Eli Lilly stock in Canada

Eli Lilly is a drug manufacturers - general business based in the US. Eli Lilly stocks (LLY) are listed on the NYSE, and all prices are listed in US Dollars.

Its last market close was $910.55, which is a decrease of 2.13% over the previous week. Eli Lilly employs 50,000 staff and has a trailing 12-month revenue of around $65.2 billion.

Keep reading to see up-to-date Eli Lilly stock price and performance data, along with a step-by-step guide for how to buy Eli Lilly stock in Canada.

Eli Lilly (LLY) stock summary

Company stock name	Eli Lilly and Company
Stock ticker symbol	LLY
Exchange	NYSE
Open	$913.49
High	$926.78
Low	$907.23
Close	$910.55
Adjusted closing	$910.55
Volume The number of stocks traded during the day	2,816,106
52-week stock price range	$620.46 – $1,132.06
Where to buy Eli Lilly stock	Buy on CIBC Investor's Edge

The values in this table are accurate as of the market close on March 22, 2026, and all amounts are in USD.

Can I buy Eli Lilly stock in Canada?

Yes, you can buy Eli Lilly stock in Canada. You simply need to open a brokerage account with an online trading platform that supports stocks on the NYSE exchange. Platforms like Interactive Brokers will allow you to directly buy Eli Lilly stock from within Canada.

Dive deeper: Detailed guide on how to buy stocks in Canada

Our top picks for where to buy Eli Lilly and Company stock

Eli Lilly stock chart (NYSE: LLY)

This chart tracks Eli Lilly stock price performance over time.

Eli Lilly stock price

Eli Lilly's stock price at the last available market close was $910.55 (as of March 22, 2026). For comparison, seven days ago Eli Lilly's stock price was $930.35. A full 30 days ago it was $1,009.52, and a year ago it was $864.90.

Is Eli Lilly stock a buy or sell right now?

The technical analysis gauge above shows real-time buy or sell ratings and analysis for Eli Lilly stock based on your selected timeframe. It uses three widely followed indicators—moving averages, oscillators and pivots—but this does not represent investment advice or a guarantee of success. Finder may not concur with these signals and accepts no responsibility for the performance of your stocks.

Can I buy Eli Lilly stock on the TSX?

No, you cannot buy Eli Lilly stock on the TSX because Eli Lilly stock is not listed on the TSX. Instead, Eli Lilly stock is listed on the NYSE under the symbol "LLY."

That said, if you're wondering how to invest in Eli Lilly stock in Canada, you still have the option to do so by opening a trading account with a Canadian brokerage that gives you access to NYSE, like Interactive Brokers.

Dive deeper: Our picks for the best stocks to buy right now in Canada

Eli Lilly stock dividends

Eli Lilly dividend payout ratio: 25.73% of net profits

Recently Eli Lilly has paid out, on average, around 25.73% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.68% of the current stock value.

This means that, over a year, based on recent payouts (which are sadly no guarantee of future payouts), Eli Lilly shareholders could enjoy a 0.68% return on their shares in the form of dividend payments. In Eli Lilly's case, that would currently equate to about $6.00 per share.

While Eli Lilly's payout ratio might seem fairly standard, it's worth remembering that Eli Lilly may be investing much of the rest of its net profits in future growth.

Eli Lilly's most recent dividend payout was on March 10, 2026. The latest dividend was paid out to all shareholders who bought their stocks by February 13, 2026 (the "ex-dividend date").

Eli Lilly stock performance metrics

Here are some common key metrics for Eli Lilly stock that analysts often use to help gauge a stock's value—P/E ratio, PEG ratio and EBITDA.

• Eli Lilly's P/E ratio

  Eli Lilly's current share price divided by its per-share earnings (EPS) over the past 12 months gives a trailing price/earnings (P/E) ratio of roughly 40x. In other words, Eli Lilly shares trade at around 40 times recent earnings.

  That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the stock or simply that they're over-valued.

• Eli Lilly's PEG ratio

  Eli Lilly's price/earnings-to-growth (PEG) ratio is calculated by dividing its P/E ratio by its earnings growth, which comes out to about 0.9758. A lower ratio can suggest a stock offers better value, while a higher ratio may suggest worse value.

  The PEG ratio provides a broader view than the P/E ratio alone, as it factors in Eli Lilly's expected earnings growth. By accounting for growth, investors can use the PEG ratio to compare the valuations of multiple high-growth companies.

• Eli Lilly's EBITDA

  Eli Lilly's EBITDA (earnings before interest, taxes, depreciation and amortization) is $31.7 billion. EBITDA is a measure of a company's overall financial performance and is often used as a proxy for a company's profitability.

Has Eli Lilly stock ever split?

Eli Lilly's stocks were split on a 2:1 basis on October 15, 1997. So, if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Eli Lilly stocks, just the quantity.

However, indirectly, the new 50% lower stock price could have impacted the market appetite for Eli Lilly stocks, which in turn could have impacted Eli Lilly's stock price.

How volatile is Eli Lilly stock?

Over the last 12 months, Eli Lilly's stocks price has ranged from $620.46 to as high as $1,132.06. Eli Lilly's beta measurement of stock volatility is 0.43. For comparison, the market () average beta is 1. This would suggest that Eli Lilly's stocks are less volatile than average (on this exchange).

Some analysists use "beta" to gauge a stock's volatility. Beta is a popular way to measure a stocks volatility in relation to the market. Here is a breakdown of Eli Lilly's beta stock volatility rating.

Eli Lilly and Company company and revenue performance

Market Capitalization The total market value of Eli Lilly's outstanding shares	$821.7 billion
Gross profit (TTM)	$54.1 billion
Operating margin (TTM)	44.90%
Profit margin	31.67%
Revenue (TTM)	$65.2 billion
Return on assets (TTM)	19.42%
Return on equity (TTM)	101.16%
Earnings per share (TTM)	$22.94
50-day moving stock price average The average share price over the last 50 days	$1,031.69
200-day moving stock price average The average share price over the last 200 days	$890.93

All dollar amounts in this table are in USD. TTM refers to the "trailing 12 months." All values are accurate as of the market close on March 22, 2026.

Eli Lilly company profile

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

It also provides oncology products, such as Cyramza for the second-line treatment of gastric cancer or gastro-esophageal junction adenocarcinoma; Erbitux for colorectal cancers and head and neck cancers; Inluriyo for breast cancer; Jaypirca for chronic lymphocytic leukemia or small lymphocytic lymphoma; Retevmo for the treatment of metastatic NSCLC; TYVYT for classic hodgkin's lymphoma; and Verzenio for breast cancer. In addition, the company offers immunology products, which include Ebglyss for severe atopic dermatitis; Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Omvoh for ulcerative colitis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis.

Further, it provides Emgality for migraine prevention and episodic cluster headache, as well as Kisubla for symptomatic Alzheimer's disease. The company has collaborations with Boehringer Ingelheim Pharmaceuticals, Inc. for the Jardiance product family; and F.

Hoffmann-La Roche Ltd and Genentech, Inc. for lebrikizumab, as well as license agreements with Almirall, S.

• Common company-related questions about Eli Lilly

  What percentage of Eli Lilly is owned by insiders or institutions?
  Currently 0.187% of Eli Lilly stocks are held by insiders and 84.749% by institutions.

  How many people work for Eli Lilly?
  Latest data suggests 50,000 work at Eli Lilly.

  When does the fiscal year end for Eli Lilly?
  Eli Lilly's fiscal year ends in December.

  Where is Eli Lilly based?
  Eli Lilly's address is: Lilly Corporate Center, Indianapolis, IN, United States, 46285

  What is Eli Lilly's ISIN number?
  Eli Lilly's international securities identification number is: US5324571083

  What is Eli Lilly's CUSIP number?
  Eli Lilly's Committee on Uniform Securities Identification Procedures number is: 532457108

Compare trading platforms to buy Eli Lilly and Company stock

Compare special offers, low fees and a wide range of investment options among popular trading platforms in Canada. Note that the dollar amounts in the table below are in CAD.

Related: Compare the best stock trading platforms in Canada

Do I have to pay tax on gains from Eli Lilly stock sales in Canada?

Yes, you'll need to pay taxes in Canada on investment income, which includes any profit from selling Eli Lilly stock. The CRA taxes investment income from stocks in Canada based on three main factors:

1. Investment income. Investment income includes money earned from interest, dividends or capital gains, which may affect how much you have to pay in taxes on stock sales in Canada.
2. Investor type. Your investment income will be taxed differently depending on whether you're a regular investor or a day trader (which means you buy and trade stocks on a daily basis as your primary form of income).
3. Tax bracket. The higher your tax bracket, the more you'll pay on income from stock sales. Your tax bracket depends on your gross income (minus deductions).

You can learn more about the tax implications of selling stocks in Canada here.

Frequently asked questions about Eli Lilly stock

• Can I buy Eli Lilly stock directly as a Canadian investor?

  Yes, Canadian investors can buy Eli Lilly stock directly through various online brokerage platforms available in Canada. You can compare trading platform options and fees for buying Eli Lilly stock in our table here.

• How much is Eli Lilly stock worth?

  As of the last market close (on March 22, 2026), Eli Lilly stock is worth $910.55 per share.

• Can Canadians buy American stocks?

  Yes, Canadians can buy American stocks through Canadian trading platforms that give access to American stock exchanges such as the NYSE and Nasdaq. The good news is that most Canadian brokerage platforms, like Questrade, Interactive Brokers, Moomoo and Wealthsimple, give access to US exchanges. Read our full guide on how to buy US stocks in Canada to learn more.

• Can I buy fractional shares of Eli Lilly stock?

  Yes, it may be possible to buy fractional shares of Eli Lilly stock depending on the trading platform you're signed up with. Fractional shares can allow you to invest in Eli Lilly stock even when you can't afford its full share price. You can read our full guide to how fractional shares work to learn more.

  The table below shows trading apps in Canada that offer fractional shares:

  4 of 4 results

  Finder Score	Available Asset Types	Account Types	Stock Trading Fee	Monthly Account Fee
  Promoted Finder Score 9.6 Excellent Questrade	Finder Score 9.6 Excellent	Stocks, Bonds, Options, Mutual Funds, Index Funds, ETFs, Forex, GICs, Precious Metals, IPOs	RRSP, RESP, RRIF, TFSA, Personal, Joint, FHSA, Margin	$0	$0	Finder exclusive: Get $50 cash back with the Questrade promo code FINDER100. Offer ends April 13, 2026. T&Cs apply.	Go to site View details Compare product selection Compare	loading
  Finder Score 8.6 Great Wealthsimple	Finder Score 8.6 Great	Stocks, Options, ETFs, Cryptocurrency	RRSP, TFSA, Personal, Margin	$0	$0	Get up to a 3% match. Win a $3M home. T&Cs apply. Valid until March 31.	Go to site View details Compare product selection Compare	loading
  Finder Score 9.4 Excellent Interactive Brokers	Finder Score 9.4 Excellent	Stocks, Bonds, Options, Index Funds, ETFs, Forex, Currencies, Futures	RRSP, TFSA, Personal, Joint, Business, FHSA, Margin	Min $1.00, Max 0.5%	$0	View details Compare product selection Compare	loading
  Finder Score 8.6 Great Moomoo	Finder Score 8.6 Great	Stocks, Options, ETFs	RRSP, TFSA, Personal, FHSA, Margin	$1.49/stock	$0	Get up to $4,600+ in trading perks T&Cs apply..	View details Compare product selection Compare	loading

  loading

  Load More

  Showing 4 of 4 results

  Finder Score for stock trading platforms

  To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score, the better the platform—it's that simple.

  Read the full methodology

Related: New to stock trading? Compare brokers and get tips for investing.

Important information: Powered by Finder.com. This information is general in nature and is no substitute for professional advice. It does not take into account your personal situation. This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for most investors. You do not own or have any interest in the underlying asset. Capital is at risk, including the risk of losing more than the amount originally put in, market volatility and liquidity risks. Past performance is no guarantee of future results. Tax on profits may apply. Consider the Product Disclosure Statement and Target Market Determination for the product on the provider's website. Consider your own circumstances, including whether you can afford to take the high risk of losing your money and possess the relevant experience and knowledge. We recommend that you obtain independent advice from a suitably licensed financial advisor before making any trades.